CCR2 Antikörper
Kurzübersicht für CCR2 Antikörper (ABIN783845)
Target
Alle CCR2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- This antibody antibody detects ~42 kDa of CCR2.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human, mouse, rat
-
Aufreinigung
- Affinity chromatography
-
Immunogen
- Synthetic peptide surrounding to amino acid 353 of rat CCR2
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Phosphate buffered saline (PBS), pH 7.2, containing 30 % glycerol and 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20 °C. For long term storage, aliquot and store at -70 °C.
-
-
- CCR2 (Chemokine (C-C Motif) Receptor 2 (CCR2))
-
Andere Bezeichnung
- CD192 / CCR2
-
Hintergrund
- Chemokines play important roles in inflammation and critical for the recruitment of effector immune cells to sites of infection. Chemokines activate leukocytes by binding to G protein coupled receptors. The ever-growing chemokine receptor subtypes can be divided into 2 major groups, CXCR and CCR, based on the 2 major classes of chemokines. One of the CCR receptors, CCR1, is expressed on neutrophils, monocytes, lymphocytes, and eosinophils and binds the leukocyte chemoattractant and hemopoiesis regulator macrophage-inflammatory protein (MIP-1 ), eotaxin, as well as several other related chemokines. Mice lacking the chemokine receptor CCR1 have defects in neutrophil trafficking and proliferation.Synonyms: C-C CKR-2, C-C chemokine receptor type 2, CC-CKR-2, CCR-2, CMKBR2, MCP1-Receptor, Monocyte chemoattractant protein 1 receptor
-
Gen-ID
- 729230
-
NCBI Accession
- NP_001116513
-
UniProt
- P41597
-
Pathways
- cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-